GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Contingent Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹3.73 Cr | ₹4.03 Cr | ₹4.00 Cr | ₹3.88 Cr | ₹3.72 Cr |
What is the latest Contingent Liabilities ratio of GUJARAT THEMIS BIOSYN ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹3.73 Cr |
Mar2023 | ₹4.03 Cr |
Mar2022 | ₹4.00 Cr |
Mar2021 | ₹3.88 Cr |
Mar2020 | ₹3.72 Cr |
How is Contingent Liabilities of GUJARAT THEMIS BIOSYN Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹3.73 Cr | -7.56 | |
Mar2023 | ₹4.03 Cr | 0.98 | |
Mar2022 | ₹4.00 Cr | 3.10 | |
Mar2021 | ₹3.88 Cr | 4.17 | |
Mar2020 | ₹3.72 Cr | - |
Compare Contingent Liabilities of peers of GUJARAT THEMIS BIOSYN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUJARAT THEMIS BIOSYN | ₹2,313.0 Cr | -19.5% | -34.5% | 4.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,259.0 Cr | 0.5% | -3.4% | 13.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,917.0 Cr | -2.2% | 0.3% | 58.8% | Stock Analytics | |
CIPLA | ₹119,705.0 Cr | 2.2% | 3.9% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,953.9 Cr | -1.5% | -7% | -5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹91,889.3 Cr | -2.3% | -7.4% | 3.7% | Stock Analytics |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUJARAT THEMIS BIOSYN | -19.5% |
-34.5% |
4.4% |
SENSEX | -0.4% |
-1.4% |
5.4% |
You may also like the below Video Courses